SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients With Nonmuscle Invasive Bladder Cancer and Recurrence After 2 Prior Courses of Intravesical Bacillus Calmette-Guérin
Journal of Urology - Netherlands
doi 10.1016/j.juro.2013.04.031
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2013
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)